Schedule a focused, confidential Strategic Program Review to get clarity on your most pressing development challenges and a practical path forward for your oncology program.

​

Every review is a direct working session with Dr. Kern, focused on giving you immediate, high-value input. You'll come away with:

​

• A medical assessment of whether your program addresses a real unmet need.

• A review of your translational and biomarker plans.

• An evaluation of your regulatory readiness and the likely hurdles on your registration pathway.

• Recommendations for asset positioning and value.

• Clear next steps to move the program forward.

​​

Every conversation is confidential and grounded in rigorous clinical and regulatory science. Share a few details below and Dr. Kern will follow up with you promptly.